A resource for producing medical isotopes to aid in diagnosing and treating diseases.
Official title: A National, Theranostic Cyclotron Resource to Drive Fundamental and Translational Medical Science
Funded at University of Wisconsin-Madison · NIH-10795184 · Data updated 2026-11-12
This study is about building a new facility at the University of Wisconsin-Madison to create special medical materials that help doctors see and treat conditions like Alzheimer's and cancer, so patients can get better and more personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 14, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2023 |
| Award (this year) | $8,000,000 |
| NIH project number | 1C06OD036005-01 |
| Project ID | NIH-10795184 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals diagnosed with Alzheimer's disease or cancers requiring advanced imaging and treatment options.
✕Less likely to help
Patients with conditions unrelated to Alzheimer's disease or cancer may not receive direct benefits from this research.
What this research studies
This research focuses on establishing a new cyclotron facility at the University of Wisconsin-Madison to produce radionuclides used in medical imaging and treatment. By enhancing the production capacity of various isotopes, including those for Alzheimer's disease and cancers, the project aims to support both fundamental and translational medical science. Patients may benefit from improved diagnostic tools and targeted therapies that utilize these radionuclides, which are essential for advancing personalized medicine. The facility will cater to a wide range of clinical and research applications, addressing the growing demand for these critical resources.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic and therapeutic options for patients with Alzheimer's disease and various cancers.
How similar studies have gone: Previous research has shown success in using cyclotron-produced radionuclides for medical applications, indicating a promising approach for this project.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Golden, Robert Neal — University of Wisconsin-Madison
- Study coordinator: Golden, Robert Neal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.